Author

Ricky D. Edmondson

University of Arkansas for Medical Sciences

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Assay:DNA methylation· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

Alan J. TackettiD· 3 shared Samuel G. MackintoshiD· 2 shared Stephanie D. ByrumiD· 2 shared Benjamin Aaron GarciaiD· 1 shared Bo PaniD· 1 shared Boris L. ZybailoviD· 1 shared Charity L. WashamiD· 1 shared Chenxi XuiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Alan J. TackettORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

YY1 relieves p300 autoinhibition to promote histone acetylation in advanced prostate cancer, enhancing the oncogenic signaling of Androgen Receptor Splice Variant 7

Chenxi Xu, Dongyu Wu, Bo Pan, Xiaoxiao Ren, Samuel G. Mackintosh, Kanishk Jain, Natarajan V. Bhanu, Ricky D. Edmondson, Xin Liu, Benjamin Aaron Garcia, Alan J. Tackett, Jian Jun Jin, Gang Greg Wang, Ling Cai

This study shows YY1 enhances p300 acetyltransferase activity in CRPC, promoting histone acetylation and oncogenic gene expression, and identifies a potential therapeutic target for overcoming drug resistance.

bioRxiv · Aug 4, 2025 · PreprintCancer Biology

Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy

Kanishka Manna, Prashanthi Dharanipragada, Duah Alkam, Nathan L. Avaritt, Charity L. Washam, Michael Scott Robeson, Tung-Chin Chiang, Ricky D. Edmondson, Samuel Mackintosh, Zhentao Yang, Yan Wang, Shirley Lomeli, Gatien Moriceau, Stephanie D. Byrum, Roger S. Lo, Alan J. Tackett

The paper presents a proteogenomic approach to identify resistance-specific alterations in melanoma PDX models treated with MAPK inhibitors using custom curated databases.

bioRxiv · Feb 15, 2022 · PreprintBioinformatics

Metaproteomics Reveals Potential Mechanisms by which Dietary Resistant Starch Supplementation Attenuates Chronic Kidney Disease Progression in Rats

Boris L. Zybailov, Galina V. Glazko, Yasir Rahmatallah, Dmitry S. Andreyev, Taylor McElroy, Oleg K. Karaduta, Stephanie D. Byrum, Lisa Dwyer Orr, Alan J. Tackett, Samuel G. Mackintosh, Ricky D. Edmondson, Dorothy A. Kieffer, Roy Joseph Martin, Sean H. Adams, Nosratola D. Vaziri, John M. Arthur

The paper uses metaproteomics to analyze cecum contents in CKD rats with and without resistant starch, revealing shifts in gut microbiota and host proteins associated with improved CKD outcomes.

PLoS ONE · Jan 30, 2019Peer-reviewedSystems Biology